AzTrials
AzTrials

Occupational TherapyNCT06199817

The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia

A study testing occupational therapies in people with Occupational Therapy and Schizophrenia, run by Ege University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objective: This study aimed to evaluate the effect of multiple occupational therapies on functional remission and subjective recovery of individuals with schizophrenic disorder. Methods: 26 people with schizophrenic disorder were divided into two groups using a random number table. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Occupational Therapy, Schizophrenia, Remission
What is being tested?
occupational therapies
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
No sites listed yet
Study dates
1 Jun 2016to 19 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Being in the 18-65 age group
  • have been diagnosed with schizophrenia for at least one year
  • be in remission of the disease
  • volunteering to participate in research
  • not have any physical health problems that would prevent their participation in the research

Who cannot join

  • have a physical health problem that prevents participation in the research
  • Having a communication problem
  • not willing to participate in research

About this study

Official title: The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Patients With Schizophrenia: A Randomized Controlled Trial

Objective: This study aimed to evaluate the effect of multiple occupational therapies on functional remission and subjective recovery of individuals with schizophrenic disorder. Methods: 26 people with schizophrenic disorder were divided into two groups using a random number table. The intervention group participated in routine community mental health center services and a total of 24 sessions of occupational therapies three times a week, while the control group participated in routine community mental health center services.

Read the detailed description

Background: Occupational therapies are one of the psycho-social intervention methods used in the treatment of serious mental disorders characterized by disability, such as schizophrenia.

Objective: This study aimed to evaluate the effect of multiple occupational therapies on functional remission and subjective recovery of individuals with schizophrenic disorder.

Methods: 26 people with schizophrenic disorder were divided into two groups using a random number table. The intervention group participated in routine community mental health center services and a total of 24 sessions of occupational therapies three times a week, while the control group participated in routine community mental health center services. Data were collected using the Subjective Recovery Assessment Scale and the Functional Remission of General Schizophrenia Scale.

Being tested
occupational therapies
Keywords
Shizophrenic Disorder, Occupational Therapy, Remission, Well-Being, Psychological
Medical subject headings
Schizophrenia, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • occupational therapiesBehavioural

    music, garden-soil and sports practices for individuals diagnosed with schizophrenic disorder

Study groups in NCT06199817
Study groupRoleWhat they receive
Intervention GroupExperimentalThe intervention group was informed about the research. The intervention group consists of patients diagnosed with schizophrenic disorder. Music, sports and garden-soil activities were applied to the intervention group.
Receives: Behavioral: occupational therapies
Control GroupNo interventionThe control group was informed about the research.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Remission of General Schzophrenia Scale (Pre Test)

    The scale is a 5-point Likert type scale consisting of 19 items. The minimum score obtained from the scale is 19 points and the maximum score is 95 points. High scores from the scale indicate high functionality, while low scores from the scale indicate low functionality. Scale scores were expected to be low in the pretest.

    Measured: 2 month

  2. Subjective Recovery Assessment Scale (Pre Test)

    The scale is a 5-point Likert type consisting of 17 items. The lowest score from the scale is 17 and the highest score is 85. Higher scores from the scale indicate that the individual perceives himself as more improved. Scale scores were expected to be low in the pretest.

    Measured: 2 month

Secondary outcomes (2)
  1. Functional Remission of General Schzophrenia Scale (Post Test)

    The scale is a 5-point Likert type scale consisting of 19 items. The minimum score obtained from the scale is 19 points and the maximum score is 95 points. High scores from the scale indicate high functionality, while low scores from the scale indicate low functionality. "Functional Remission of General Schzophrenia Scale" score was expected to increase in the post test.

    Measured: Forth month

  2. Subjective Recovery Assessment Scale (Post Test)

    The scale is a 5-point Likert type consisting of 17 items. The lowest score from the scale is 17 and the highest score is 85. Higher scores from the scale indicate that the individual perceives himself as more improved. It was expected that the score obtained from the scale in the post-test would be high.

    Measured: Forth month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2024
  2. Study start1 Jun 2016
  3. Primary completion1 May 2022
  4. Study completion19 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06199817
Sponsor's protocol ID
16-5.1/7
Status last verified
Dec 2023
First submitted
14 Dec 2023
Last updated
6 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing occupational therapies in people with Occupational Therapy and Schizophrenia, run by Ege University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Remission of General Schzophrenia Scale (Pre Test) (time frame: 2 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in